-
5-(N,N-dimethyl)-Amiloride: Assay Design Guide
2026-09-11
5-(N,N-dimethyl)-Amiloride hydrochloride is a selective Na+/H+ exchanger probe for linking ion transport with endothelial barrier biology. This guide shows how to use it alongside moesin, permeability, and inflammatory readouts without confusing pharmacological perturbation with biomarker evidence.
-
GSH and GSSG Assay Kit for Redox Studies
2026-09-11
Map hypoxia-linked redox remodeling with paired measurements of reduced and oxidized glutathione across cells, tissues, plasma, and red blood cells. This workflow combines reduced glutathione detection, selective GSSG analysis, and practical controls for oxidative stress research.
-
PPM-18: Mapping NF-κB–iNOS Control
2026-09-10
PPM-18 is an iNOS expression inhibitor that connects NF-κB signaling pathway inhibition with measurable inflammatory outputs. This article develops a rigorous assay strategy and explains how bone-remodeling research can inform, but not overstate, PPM-18 applications in sepsis research and inflammation modulation.
-
p21-ELP Delivery Suppresses Glioblastoma
2026-09-10
The reference study shows that the engineered p21-ELP1-Bac construct can enter U87, GBM43, and GBM6 glioblastoma cells and suppress proliferation, primarily through cytostatic rather than strongly apoptotic effects. Its value lies in combining a p21-derived cell-cycle inhibitor with an elastin-like polypeptide and cell-penetrating module, while revealing meaningful differences in sensitivity among glioblastoma models.
-
Angiotensin II in Vascular Aging Research
2026-09-09
Build reproducible endothelial senescence, vascular remodeling, and abdominal aortic aneurysm workflows with a defined Angiotensin II peptide stimulus. This guide connects receptor-proximal signaling to MFN2, mitochondrial, and senescence readouts while providing practical dosing, handling, and troubleshooting strategies.
-
Glycogen Colorimetric Assay Kit II in Exercise Biology
2026-09-09
The Glycogen Colorimetric Assay Kit II enables interference-conscious glycogen measurement in exercise and circadian studies. This article explains how its hydrolysis-based chemistry can clarify what endurance-training data do—and do not—reveal about glycogen biology.
-
Reserpine (N1867): Practical Lab Guide
2026-09-08
Reserpine (SKU N1867) provides a defined research reagent for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. Its water and ethanol insolubility, DMSO-dependent preparation, and potent biological activity require controlled handling; it is not intended for diagnostic, therapeutic, clinical, or veterinary use.
-
Reactive Oxygen Species Assay Kit for FLASH-RT
2026-09-08
Use live-cell DCFH-DA fluorescence to connect radiation exposure with oxidative stress, cytotoxicity, and downstream biology. This workflow translates the FLASH-RT nanoparticle findings into practical ROS controls, time-course experiments, and troubleshooting decisions for cancer research oxidative stress studies.
-
Taihangia rupestris: UPLC-MS/MS and Bioactivity
2026-09-07
A 2026 RSC Advances study integrated UPLC-MS/MS, multivariate analysis, complementary antioxidant assays, α-glucosidase inhibition, affinity screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest flavonoid- and phenolic-associated activity profile, supporting cultivation as a conservation-compatible source for natural product antioxidant evaluation while clarifying the limits of in vitro evidence.
-
Tetrazolium (chloride) in Ischemic Tissue Assays
2026-09-07
Tetrazolium (chloride) converts dehydrogenase activity into a visible Tetrazolium Red signal for cell, brain, and cardiac viability studies. This guide translates the chemistry into practical tissue-staining and mitochondrial assay workflows, with optimization parameters and troubleshooting for ischemic injury research.
-
NAT1–ENO1–Lactate Signaling in Colorectal Cancer
2026-09-05
A 2026 MedComm study defines a metabolic–immune circuit in colorectal cancer in which NAT1 restrains ENO1 activity and lactate production, while NAT1 loss promotes TRAF6-dependent stabilization of PD-L1. The findings connect glycolytic output with immune checkpoint regulation and provide a preclinical framework for studying how lactate metabolism may influence responses to PD-1 or PD-L1 blockade.
-
Lactate Workflows for Metabolic–Immune Research
2026-09-04
Use L-lactate as both a quantitative metabolic readout and a controlled signaling input across glycolysis, hypoxia, mitochondrial, and tumor–immune experiments. This workflow-oriented guide connects careful compartmental sampling with the NAT1–ENO1–lactate mechanism and practical controls for reproducible cell-based assays.
-
A-769662: Designing Better AMPK Assays
2026-09-04
A-769662 is a reversible AMPK activator for dissecting energy metabolism, autophagy, and proteasome-linked phenotypes. This guide translates recent AMPK–ULK1 findings into practical assay-design and interpretation strategies.
-
WST-8 Glucose Uptake Assay Kit Workflow
2026-09-03
Build a non-radioactive glucose uptake assay around 2-deoxyglucose transport, enzymatic amplification, and 450 nm colorimetric detection. This workflow connects Galectin-1–FIP200 biology with functional insulin-resistance measurements while highlighting controls, normalization, and troubleshooting for hepatic steatosis models.
-
BI 2536: A Better Way to Read PLK1 Responses
2026-09-03
BI 2536 is a potent PLK1 inhibitor for dissecting mitotic arrest, apoptosis, and drug response. This guide combines PLK1 biology with a quantitative assay framework that distinguishes growth suppression from true cancer-cell killing.